References
- Sarris AH, Kempin S, Berman E, Michaeli J, Little C, Andreeff M, Gee T, Straus D, Gansbacher D, Filippa D, etal. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood 1992;79:1305–1310.
- Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Dissemi-nated intravascular coagulation in adult acute lymphoblastic leukemia: Frequent complications with fibrinogen levels less than 100 mg/d1. Leuk Lymphoma 1996;21: 85–92.
- Higuchi T, Mori H, Niikura H, Omine M, Okada S, Terada H. Disseminated intravascular coagulation in acute lympho-blastic leukemia at presentation and in early phase of remission induction therapy. Ann Hematol 1998;76:263–269.
- Törnebohm E, Lockner D, Paul C. A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972–1991. Eur J Haematol 1993;50: 160–167.
- Solano C, Lopes J, Gomez N, Fernandez-Ranada JM. Acute lymphoblastic leukemia: Hypofibrinogenemia with a low incidence of clinical complications is often found during induction remission therapy. Blood 1992;80:1366–1367.
- De Stefano V, Gugliotta L, Mazzucconi MG, Leone G, Mandelli F. Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Blood 1993;81:2468–2469.
- Sletnes KE, Godal HC, Wisloff. Disseminated intravascular coagulation (DIC) in adult patients with acute leukaemia. Eur J Haematol 1995;54:34–38.
- Ribeiro RC, Pui C-H. The clinical and biological correlations of coagulopathy in children with acute leukemia. J Chin Oncol 1986;4:1212–1218.
- Abshire TC, Gold SH, Odom LF, Carson SD, Hathaway WE. The coagulopathy of childhood leukaemia. Thrombin activa-tion or primary fibrinolysis? Cancer 1990;66:716–721.
- Mitchell L, Hoogendoorn H, Giles AR, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: Risk of thrombotic complica-tions in L'asparaginase-induced antithrombin III deficiency. Blood 1994;83:386–391.
- Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM, Andrew ME. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol/Oncol 1994;16:120–126.
- Oner AF, Giirgey A, Kirazli S, Okur H, Tung B. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase. Leuk Lympho-ma 1999;33:361–364.
- Giornadno P, Del Vecchio GC, Santoro N, Arcamon G, Coppola B, Altomare M, Schettini F, Iolascon A, De Mattia D. Thrombin generation in children with acute lymohoblastic leukemia: Effect of leukemia immunophenotypic subgroups. Pediatr Hematol Oncol 2000;17:667–672.
- Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of the acute leukaemias. Br J Haematol 1976;33:451–458.
- Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Fried-man A, Gee TS, Dowling M, Kempin S, Straus DJ, Koiziner B, et al. Treatment of acute lymphoblstic leukemia in adults: Results of the L-10 and L-10M protocols. J Chin Oncol 1983;1: 462–470.
- Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, Shiku H, Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003;74:17–22.
- Champion LAA, Luddy RE, Schwartz AD. Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features. Cancer 1978;41:1642–1646.
- Nur S, Anwar M, Saleem M, Ahmad PA. Disseminated intravascular coagulation in acute leukaemias at first diagnosis. Eur J Haematol 1995;55:78–82.
- Leone G, Gugliotta L, Mazzucconi MG, De Stefano V, Belmonte MM, Dragoni F, Specchia G, Centra A, Gamba G, Camera A, Mandelli F. Evidence of a hypercoagulable state in patients with acute lyphoblastic leukemia treated with low dose of E. coli L-asparaginase: A GIMEMA study. Thromb Haematost 1993;69:12–15.
- Saito M, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Ito K, Matsuda T. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy. Am J Hematol 1989;32:20–23.
- Chorba TL, Orenstein JM, Ney AB, Schwarts BS, Alabaster O, Kessler CM, Cohen P, Schlof RS. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity. Cancer 1985;55:675–681.
- Tanaka M, Yamanishi H. The expression of tissue factor antigen and activity on the surface of leukemia cells. Leukemia Res 1993;17:103–111.
- Alession MG, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990;45: 78–81.
- Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004;124:567 —576.
- Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, Bennett JM. Precursor B-cell and T-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours and haematopoie-tic and lymphoid tissues. Lyon: IARC Press; 2001. pp. 109–117.